Detection of markers of hepatitis viral infection in the tissue of bile duct carcinoma

Chinese Medical Journal

Volumn 121, Issue 12, 2008, Pages 1143-1144

  Liu, Hou Bao ^a   Qian, Zhen Yu ^a   Wang, Bing Sheng ^a   Tong, Sai Xiong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Bile duct carcinoma; Biomarker; Hepatitis viral infection

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VIRUS S PROTEIN; HEPATITIS B VIRUS X PROTEIN; HEPATITIS B(E) ANTIBODY; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER LOCALIZATION; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE IDENTIFICATION; HEPATITIS B; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER PARENCHYMA; MALE; POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

EID: 51149098961     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200806020-00022     Document Type: Article

References (9)

1. Gao JD, Shao YF, Xu Y, Ming LH, Wu ZY, Lin GT, et al. Tight association of hepatocellular carcinoma with HBV infection in north China. Hepatobiliary Pancreat Dis Int 2005; 4: 46-49.
2. Gao Y, Jiang Q, Zhou X, Ding B, Wang R, Zhao G, et al. HBV infection and familial aggregation of liver cancer: an analysis of case-control family study. Cancer Causes Control 2004; 15: 845-850.
3. Kabayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with HCV-related cirrhosis. Cancer 2000; 88: 2471-2477.
4. Harris RA, Chen G, Lin WY, Shen FM, London WT, Evans AA. Spontaneous clearance of high-titer serum HBV DNA and risk of hepatocellular carcinoma in a Chinese population. Cancer Causes Control 2003; 14: 995-1000.
5. Wang BS, Qin J, Deng J, Zhang BH, Han TQ, Shen MC, et al. Investigation and analysis in the diagnosis and treatment of biliary tract cancers in Shanghai. Chin J Surg (Chin) 2005; 43: 1-5.
6. Kabayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with HCV-related cirrhosis. Cancer 2000; 88: 2471-2477.
7. Cheng AS, Chan HL, Leung WK, To KF, Go MY, Chan JY, et al. Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellutar carcinoma: implication of HBx in upregulation of COX-2. Mod Pathol 2004; 17: 1169-1179.
8. Hwang GY, Lin CY, Huang LM, Wang YH, Wang JC, Hsu CT, et al. Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma. J Gin Nficrobiol 2003; 41: 5598-5603.
9. Wang BS, Qian ZY, Liu HB, Qin J, Tong SX. Initial investigation of the cause or biliary tract cancer. Chin J Gene Surg (Chin) 2004; 19: 642-643.